A detailed history of Ardevora Asset Management LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ardevora Asset Management LLP holds 139,106 shares of EW stock, worth $10.5 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
139,106
Previous 263,429 47.19%
Holding current value
$10.5 Million
Previous $18.3 Million 41.88%
% of portfolio
0.94%
Previous 0.9%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$61.71 - $77.76 $7.67 Million - $9.67 Million
-124,323 Reduced 47.19%
139,106 $10.6 Million
Q3 2023

Oct 25, 2023

BUY
$69.28 - $93.38 $18.3 Million - $24.6 Million
263,429 New
263,429 $18.3 Million
Q3 2022

Nov 04, 2022

SELL
$82.37 - $107.29 $3.65 Million - $4.76 Million
-44,329 Reduced 8.03%
508,053 $42 Million
Q2 2022

Jul 11, 2022

BUY
$86.5 - $128.27 $1.31 Million - $1.94 Million
15,100 Added 2.81%
552,382 $52.5 Million
Q1 2022

Apr 28, 2022

SELL
$101.96 - $128.34 $5.98 Million - $7.53 Million
-58,637 Reduced 9.84%
537,282 $63.2 Million
Q4 2021

Jan 31, 2022

BUY
$106.37 - $130.68 $1.85 Million - $2.27 Million
17,400 Added 3.01%
595,919 $77.2 Million
Q3 2021

Oct 15, 2021

SELL
$102.91 - $122.75 $9.76 Million - $11.6 Million
-94,800 Reduced 14.08%
578,519 $65.5 Million
Q2 2021

Jul 22, 2021

BUY
$83.84 - $104.76 $10.7 Million - $13.4 Million
128,219 Added 23.52%
673,319 $69.7 Million
Q1 2021

Apr 22, 2021

SELL
$78.68 - $90.67 $3.93 Million - $4.53 Million
-50,000 Reduced 8.4%
545,100 $45.6 Million
Q4 2020

Jan 14, 2021

BUY
$71.69 - $91.23 $42.7 Million - $54.3 Million
595,100 New
595,100 $54.3 Million
Q2 2020

Jul 28, 2020

SELL
$57.54 - $76.95 $23,016 - $30,780
-400 Closed
0 $0
Q1 2020

Apr 28, 2020

SELL
$52.41 - $81.0 $11.7 Million - $18.1 Million
-223,841 Reduced 99.82%
400 $75,000
Q4 2019

Feb 05, 2020

BUY
$71.7 - $82.09 $1.68 Million - $1.92 Million
23,400 Added 11.65%
224,241 $52.3 Million
Q3 2019

Oct 25, 2019

SELL
$61.55 - $75.43 $1.77 Million - $2.17 Million
-28,800 Reduced 12.54%
200,841 $44.2 Million
Q2 2019

Aug 01, 2019

BUY
$55.74 - $64.41 $1.52 Million - $1.76 Million
27,300 Added 13.49%
229,641 $42.4 Million
Q1 2019

Apr 24, 2019

SELL
$47.89 - $64.05 $1.77 Million - $2.37 Million
-37,000 Reduced 15.46%
202,341 $38.7 Million
Q4 2018

Jan 31, 2019

BUY
$46.41 - $56.94 $516,311 - $633,457
11,125 Added 4.87%
239,341 $36.7 Million
Q3 2018

Oct 30, 2018

SELL
$45.7 - $58.03 $338,180 - $429,422
-7,400 Reduced 3.14%
228,216 $39.7 Million
Q2 2018

Jul 30, 2018

SELL
$42.45 - $51.3 $3.42 Million - $4.13 Million
-80,584 Reduced 25.49%
235,616 $34.3 Million
Q1 2018

May 08, 2018

BUY
$37.19 - $47.45 $22,314 - $28,470
600 Added 0.19%
316,200 $44.1 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $229,772 - $267,852
6,800 Added 2.2%
315,600 $35.6 Million
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $11.2 Million - $12 Million
308,800
308,800 $33.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ardevora Asset Management LLP Portfolio

Follow Ardevora Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ardevora Asset Management LLP with notifications on news.